Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials

OBJECTIVE: Thiazolidinediones and insulin are associated with a higher risk of fractures in type 2 diabetic patients. Incretin hormones increase bone density in experimental models, but the effect of dipeptidyl peptidase-4 (DPP-4) inhibitors on bone fractures has not been reported so far. RESEARCH D...

Descripción completa

Detalles Bibliográficos
Autores principales: Monami, Matteo, Dicembrini, Ilaria, Antenore, Alessandro, Mannucci, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Reviews/Commentaries/ADA Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198283/
https://www.ncbi.nlm.nih.gov/pubmed/22025784
http://dx.doi.org/10.2337/dc11-1099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198283/
https://www.ncbi.nlm.nih.gov/pubmed/22025784
http://dx.doi.org/10.2337/dc11-1099

Ejemplares similares